Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALT | USNA | SVRA | ||
| Company | Altimmune Inc | Usana Health Sciences Inc | Savara Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 8.31 | 34.24 | 3.20 | ||
| High | 8.75 | 34.64 | 3.33 | ||
| Low | 8.18 | 33.28 | 3.12 | ||
| Last | 8.25 | 33.38 | 3.23 | ||
| Change | +0.07 | -1.33 | unch | ||
| % Change | +0.86% | -3.83% | unch | ||
| Volume | 4,899,400 | 619,700 | 2,253,300 | ||
| 20-Day Average Volume | 3,367,230 | 118,205 | 1,420,010 | ||
| Previous Close | 8.18 | 34.71 | 3.23 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.77 | 37.59 | 3.38 | ||
| 20-Day Raw Stochastic | 17.18% | 1.40% | 28.74% | ||
| 20-Day Relative Strength | 50.18% | 34.56% | 45.13% | ||
| Weighted Alpha | -12.96 | -38.85 | -33.64 | ||
| Today's Opinion | 72% Buy | 100% Sell | 100% Sell | ||
| Previous Opinion | 72% Buy | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 56% Buy | 40% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.64% since 12/13/24 | -8.90% since 12/13/24 | +0.62% since 12/13/24 | ||
| Low | 7.70 on 12/18/24 | 33.28 on 12/20/24 | 2.99 on 12/18/24 | ||
| High | 9.59 on 12/16/24 | 37.69 on 12/16/24 | 3.39 on 12/16/24 | ||
| 1-Month | |||||
| %Chg | +2.48% since 11/20/24 | -15.54% since 11/20/24 | +3.19% since 11/20/24 | ||
| Low | 7.70 on 12/18/24 | 33.28 on 12/20/24 | 2.99 on 12/18/24 | ||
| High | 10.88 on 12/04/24 | 40.78 on 11/25/24 | 3.83 on 12/06/24 | ||
| 3-Month | |||||
| %Chg | +5.91% since 09/20/24 | -13.52% since 09/20/24 | -28.06% since 09/20/24 | ||
| Low | 5.86 on 10/01/24 | 33.28 on 12/20/24 | 2.82 on 11/18/24 | ||
| High | 11.16 on 11/13/24 | 41.83 on 11/11/24 | 4.70 on 09/23/24 | ||
| 6-Month | |||||
| %Chg | +38.89% since 06/20/24 | -26.65% since 06/20/24 | -13.17% since 06/20/24 | ||
| Low | 5.28 on 08/05/24 | 33.28 on 12/20/24 | 2.82 on 11/18/24 | ||
| High | 11.16 on 11/13/24 | 48.85 on 07/17/24 | 5.11 on 07/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 586,781 | 636,223 | 554,329 | ||
| Shares Outstanding, K | 71,125 | 19,060 | 171,619 | ||
| Annual Sales | 430,000 | 921,010,000 | 0 | ||
| Annual Net Income | -88,450,000 | 63,790,000 | -54,700,000 | ||
| Last Quarter Sales | 10,000 | 200,220,000 | 0 | ||
| Last Quarter Net Income | -22,850,000 | 10,610,000 | -24,250,000 | ||
| 60-Month Beta | 0.15 | 0.89 | 0.92 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 11/12/24 | 0.56 on 10/22/24 | -0.11 on 11/12/24 | ||
| Latest Earnings Date | 11/12/24 | 02/04/25 | 11/14/24 | ||
| Most Recent Dividend | 2.910 on 02/06/17 | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 12.27 | 0.00 | ||